Spirit AeroSystems

No posts found.

Are GLP-1 Drugs Here to Stay?

We recently spoke with Nicole Bulochnik, senior vice president of drug strategy for Abarca, about what payers need to consider as demand for this group of weight-loss drugs remains high.

Payers

How Payers Use Tech to Support Healthcare Transformation

Executives at the ViVE Payer Insights event earlier this year discussed prior authorization, AI, value-based care and the role of tech to help achieve their goals.

Advertise
About
Newsletter

Our Sites

×